Citations

Clear

959 citation(s) found for "Service, F J".

Clinical, biochemical and genetic characteristics of MOGS-CDG: a rare congenital disorder of glycosylation
Shimada, Shino , Ng, Bobby G. , White, Amy , Nickander, Kim K., Turgeon, Coleman , Liedtke, Kristen, Lam, Christina , Font–Montgomery, Esperanza , Peck, Dawn , Uhles, Crescenda L , Haynes, Devon , Wheeler, Patricia G. , Bamshad, Michael J. , Nickerson, Deborah A. , Cushing, Tom, Gates, Ryan , Gomez‐Ospina, Natalia , Scalco, Fernanda B. , Martinez, Noelia Nunez, Sachdev, Rani , Malone, Stephen , Harris, Rebekah V. , Scheffer, Ingrid E. , Rosenzweig, Sergio D. , Adams, David R. , Gahl, William A. , Malicdan, May Christine V. , Raymond, Kimiyo , Wolfe, Lynne A. , Jarvik, Gail P. , White, Amy L , Liedtke, Kristen L, Peck, Dawn S, Harris, Rebekah V , Scheffer, Ingrid E , Malicdan, May Christine V , Raymond, Kimiyo M, Jarvik, Gail P , Ng, Bobby G , Lourenco, Charles , He, Miao , Umaña, Luis Alfredo , Byers, Heather M. , Smith, Lacey A. , Poduri, Annapurna , Freeze, Hudson H.

Mayo Clinic

Journal of Medical Genetics | July 5, 2022 | Volume: 59 | Issue: 11 | Pages: 1104-1115

10.1136/jmedgenet-2021-108177 | PMID 35790351 Get It

Purpose To summarise the clinical, molecular and biochemical phenotype of mannosyl-oligosaccharide glucosidase-related congenital disorders of glycosylation (MOGS-CDG), which presents with variable clinical manifestations, and to analyse which clinical biochemical assay consistently supports diagnosis in individuals with bi-allelic variants in MOGS. Methods Phenotypic characterisation was performed through an international and multicentre collaboration. Genetic testing was done by exome sequencing and targeted arrays. Biochemical assays on serum and urine were performed to delineate the biochemical signature of MOGS-CDG. Results Clinical phenotyping revealed heterogeneity in MOGS-CDG, including neurological, immunological and skeletal phenotypes. Bi-allelic variants in MOGS were identified in 12 individuals from 11 families. The severity in each organ system was variable, without definite genotype correlation. Urine oligosaccharide analysis was consistently abnormal for all affected probands, whereas other biochemical analyses such as serum transferrin analysis was not consistently abnormal. Conclusion The clinical phenotype of MOGS-CDG includes multisystemic involvement with variable severity. Molecular analysis, combined with biochemical testing, is important for diagnosis. In MOGS-CDG, urine oligosaccharide analysis via matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry can be used as a reliable biochemical test for screening and confirmation of disease.
Acute pain pathways: protocol for a prospective cohort study
Jeffery, Molly M. , Ahadpour, Mitra , Allen, Summer V. , Araojo, Richardae , Bellolio, Fernanda , Chang, Nancy, Ciaccio, Laura , Emanuel, Lindsay, Fillmore, Jonathan J., Gilbert, Gregg H. , Koussis, Patricia, Lee, Christine , Lipkind, Heather S. , Mallama, Celeste A. , Meyer, Tamra E. , Moncur, Megan, Nuckols, Teryl K. , Pacanowski, Michael , Page, David B. , Papadopoulos, Elektra J., Ritchie, Jessica , Shah, Nilay D. , Soukup, Mat, Clair, Christopher St. , Tamang, Stephen, Torbati, Sam , Wallace, Douglas W. , Zhao, Yueqin, Heckmann, Rebekah, Jeffery, Molly Moore , Allen, Summer , Fillmore, Jonathan, Bellolio, M Fernanda , Fillmore, Jonathan, Lee, Christine H. , Ross, Joseph S.

Mayo Clinic

BMJ Open | July 5, 2022 | Volume: 12 | Issue: 7 | Pages: e058782

10.1136/bmjopen-2021-058782 | PMID 35790333 Get It

Introduction Opioid analgesics are often used to treat moderate-to-severe acute non-cancer pain; however, there is little high-quality evidence to guide clinician prescribing. An essential element to developing evidence-based guidelines is a better understanding of pain management and pain control among individuals experiencing acute pain for various common diagnoses. Methods and analysis This multicentre prospective observational study will recruit 1550 opioid-naïve participants with acute pain seen in diverse clinical settings including primary/urgent care, emergency departments and dental clinics. Participants will be followed for 6 months with the aid of a patient-centred health data aggregating platform that consolidates data from study questionnaires, electronic health record data on healthcare services received, prescription fill data from pharmacies, and activity and sleep data from a Fitbit activity tracker. Participants will be enrolled to represent diverse races and ethnicities and pain conditions, as well as geographical diversity. Data analysis will focus on assessing patients’ patterns of pain and opioid analgesic use, along with other pain treatments; associations between patient and condition characteristics and patient-centred outcomes including resolution of pain, satisfaction with care and long-term use of opioid analgesics; and descriptive analyses of patient management of leftover opioids. Ethics and dissemination This study has received approval from IRBs at each site. Results will be made available to participants, funders, the research community and the public. Trial registration number NCT04509115 .
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis
Lomax-Browne, Hannah J. , Medjeral‐Thomas, Nicholas , Barbour, Sean J. , Gisby, Jack , Han, Heedeok , Fervenza, Fernando C. , Cairns, Thomas H D, Szydlo, Richard , Marks, Stephen D. , Waters, Aoife , Appel, Gerald B., D’Agati, Vivette D. , Sethi, Sanjeev , Nast, Cynthia C. , Bajema, Ingeborg M., Licht, Christoph , Cattran, Daniel C., Peters, James E. , Cook, H. Terence , Marks, Stephen D , Sethi, Sanjeev , Pickering, Matthew C , Fervenza, Fernando C , Bomback, Andrew S. , Tan, Sven‐Jean , Alpers, Charles E. , Fogo, Agnes B. , Fakhouri, Fádi

Mayo Clinic

Clinical Journal of the American Society of Nephrology | July 1, 2022 | Volume: 17 | Issue: 7 | Pages: 994-1007

10.2215/cjn.16801221 | PMID 35777834 Get It

Background and objectives C3 glomerulopathy and idiopathic Ig-associated membranoproliferative GN are kidney diseases characterized by abnormal glomerular complement C3 deposition. These conditions are heterogeneous in outcome, but approximately 50% of patients develop kidney failure within 10 years. Design, setting, participants, & measurements To improve identification of patients with poor prognosis, we performed a detailed analysis of percutaneous kidney biopsies in a large cohort of patients. Using a validated histologic scoring system, we analyzed 156 native diagnostic kidney biopsies from a retrospective cohort of 123 patients with C3 glomerulopathy and 33 patients with Ig-associated membranoproliferative GN. We used linear regression, survival analysis, and Cox proportional hazards models to assess the relationship between histologic and clinical parameters with outcome. Results Frequent biopsy features were mesangial expansion and hypercellularity, glomerular basement membrane double contours, and endocapillary hypercellularity. Multivariable analysis showed negative associations between eGFR and crescents, interstitial inflammation, and interstitial fibrosis/tubular atrophy. Proteinuria positively associated with endocapillary hypercellularity and glomerular basement membrane double contours. Analysis of second native biopsies did not demonstrate associations between immunosuppression treatment and improvement in histology. Using a composite outcome, risk of progression to kidney failure associated with eGFR and proteinuria at the time of biopsy, cellular/fibrocellular crescents, segmental sclerosis, and interstitial fibrosis/tubular atrophy scores. Conclusions Our detailed assessment of kidney biopsy data indicated that cellular/fibrocellular crescents and interstitial fibrosis/tubular atrophy scores were significant determinants of deterioration in kidney function.
Surgical versus catheter ablation in atrial fibrillation: A systematic review and meta‐analysis of randomized controlled trials
Kanitsoraphan, Chanavuth , Kewcharoen, Jakrin , Sriramoju, Anil, Shanbhag, Anusha , Ko, Nway L. Ko, Barry, Timothy , Vutthikraivit, Wasawat , Shen, Win‐Kuang , Rattanawong, Pattara , Kanitsoraphan, Chanavuth , Kewcharoen, Jakrin , Ko Ko, Nway L, Vutthikraivit, Wasawat , Rattanawong, Pattara , Sriramoju, Anil

Mayo Clinic

Journal of Cardiovascular Electrophysiology | June 30, 2022 | Volume: 33 | Issue: 10 | Pages: 2152-2163

10.1111/jce.15617 | PMID 35771487 Get It

AbstractIntroductionAtrial fibrillation (AF) is the most common cardiac arrhythmia with a high stroke and mortality rate. The video‐assisted thoracoscopic radiofrequency pulmonary vein ablation is a treatment option for patients who fail catheter ablation. Randomized data comparing surgical versus catheter ablation are limited. We performed a meta‐analysis of randomized control trials to explore the outcome efficacy between surgical and catheter radiofrequency pulmonary vein ablation in patients with AF.MethodsWe comprehensively searched the databases of MEDLINE and EMBASE from inception to December 2020. Included studies were published randomized control trials that compared video‐assisted thoracoscopic and catheter radiofrequency pulmonary vein ablation. Data from each study were combined using the fixed‐effects, generic inverse variance method of DerSimonian, and Laird to calculate odds ratios and 95% confidence intervals.ResultsSix studies from November 2013 to 2020 were included in this meta‐analysis involving 511 AF patients (79% paroxysmal) with 263 catheter ablation (mean age 56 ± 3 years) and 248 surgical ablations (mean age 52 ± 4 years). Catheter ablation was associated with increased atrial arrhythmias recurrence when compared to surgical ablation (pooled relative risk = 1.85, 95% confidence interval: 1.44−2.39, p < .001, I2 = 0.0%) but associated with less total major adverse events (pooled relative risk = 0.29, 95% confidence interval: 0.16−0.53, p < .001, I2 = 0.0%). In subgroup analysis, catheter ablation was associated with increased AF recurrence in refractory paroxysmal AF when compared to surgical ablation (pooled relative risk = 2.47, 95% confidence interval: 1.31−4.65, p = .005, I2 = 0.0%) but not in persistent AF (relative risk = 1.09, 95% confidence interval: 0.60−2.0, p = .773).ConclusionCatheter ablation was associated with higher atrial arrhythmia recurrence when compared with surgical ablation. However, our study suggests that the benefit of surgical ablation in patients with persistent AF is unclear. More studies and alternative ablation strategies investigation in persistent AF are warranted.
Towards network-guided neuromodulation for epilepsy
Piper, Rory J. , Carmichael, David W. , Litt, Brian , Tisdall, Martin , Tisdall, Martin M , Richardson, Robert Mark , Worrell, Gregory A. , Baldeweg, Torsten , Denison, Timothy

Mayo Clinic

Brain | June 30, 2022 | Volume: 145 | Issue: 10 | Pages: 3347-3362

10.1093/brain/awac234 | PMID 35771657 Get It

Abstract Epilepsy is well-recognized as a disorder of brain networks. There is a growing body of research to identify critical nodes within dynamic epileptic networks with the aim to target therapies that halt the onset and propagation of seizures. In parallel, intracranial neuromodulation, including deep brain stimulation and responsive neurostimulation, are well-established and expanding as therapies to reduce seizures in adults with focal-onset epilepsy; and there is emerging evidence for their efficacy in children and generalized-onset seizure disorders. The convergence of these advancing fields is driving an era of ‘network-guided neuromodulation’ for epilepsy. In this review, we distil the current literature on network mechanisms underlying neurostimulation for epilepsy. We discuss the modulation of key ‘propagation points’ in the epileptogenic network, focusing primarily on thalamic nuclei targeted in current clinical practice. These include (i) the anterior nucleus of thalamus, now a clinically approved and targeted site for open loop stimulation, and increasingly targeted for responsive neurostimulation; and (ii) the centromedian nucleus of the thalamus, a target for both deep brain stimulation and responsive neurostimulation in generalized-onset epilepsies. We discuss briefly the networks associated with other emerging neuromodulation targets, such as the pulvinar of the thalamus, piriform cortex, septal area, subthalamic nucleus, cerebellum and others. We report synergistic findings garnered from multiple modalities of investigation that have revealed structural and functional networks associated with these propagation points — including scalp and invasive EEG, and diffusion and functional MRI. We also report on intracranial recordings from implanted devices which provide us data on the dynamic networks we are aiming to modulate. Finally, we review the continuing evolution of network-guided neuromodulation for epilepsy to accelerate progress towards two translational goals: (i) to use pre-surgical network analyses to determine patient candidacy for neurostimulation for epilepsy by providing network biomarkers that predict efficacy; and (ii) to deliver precise, personalized and effective antiepileptic stimulation to prevent and arrest seizure propagation through mapping and modulation of each patients’ individual epileptogenic networks.
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
Snyder, Edward L. , Wheeler, Allison P. , Refaai, Majed A. , Cohn, Claudia S. , Poisson, Jessica , Fontaine, Magali J. , Sehl, Mary E. , Uhl, Lynne , Spinella, Philip C. , Fenelus, Maly , Coyle, Thomas, Becker, Joanne , Jeng, Michael , Spencer, Bryan R. , Young, Pampee P. , OʼBrien, Jennifer , Schiller, Gary J. , Roback, John D. , Malynn, Elizabeth, Jackups, Ronald , Avecilla, Scott T. , Lin, Jin‐Sying, Bentow, Stanley, Peng, Ho‐Lan, Varrone, Jeanne, Fontaine, Magali , Spinella, Philip C , Gehrie, Eric A , Spencer, Bryan R , Young, Pampee , O'Brien, Jennifer J, Avecilla, Scott T , Benjamin, Richard J , Corash, Laurence M , Cohn, Claudia S , Wheeler, Allison P , Jeng, Michael , Nooka, Ajay K. , Liles, Darla , Johnson, Andrew, Liu, Kathy

Mayo Clinic

Transfusion | June 24, 2022 | Volume: 62 | Issue: 7 | Pages: 1365-1376

10.1111/trf.16987 | PMID 35748490 Get It

AbstractBackgroundPlatelet transfusion carries risk of transfusion‐transmitted infection (TTI). Pathogen reduction of platelet components (PRPC) is designed to reduce TTI. Pulmonary adverse events (AEs), including transfusion‐related acute lung injury and acute respiratory distress syndrome (ARDS) occur with platelet transfusion.Study designAn open label, sequential cohort study of transfusion‐dependent hematology‐oncology patients was conducted to compare pulmonary safety of PRPC with conventional PC (CPC). The primary outcome was the incidence of treatment‐emergent assisted mechanical ventilation (TEAMV) by non‐inferiority. Secondary outcomes included: time to TEAMV, ARDS, pulmonary AEs, peri‐transfusion AE, hemorrhagic AE, transfusion reactions (TRs), PC and red blood cell (RBC) use, and mortality.ResultsBy modified intent‐to‐treat (mITT), 1068 patients received 5277 PRPC and 1223 patients received 5487 CPC. The cohorts had similar demographics, primary disease, and primary therapy. PRPC were non‐inferior to CPC for TEAMV (treatment difference −1.7%, 95% CI: (−3.3% to −0.1%); odds ratio = 0.53, 95% CI: (0.30, 0.94). The cumulative incidence of TEAMV for PRPC (2.9%) was significantly less than CPC (4.6%, p = .039). The incidence of ARDS was less, but not significantly different, for PRPC (1.0% vs. 1.8%, p = .151; odds ratio = 0.57, 95% CI: (0.27, 1.18). AE, pulmonary AE, and mortality were not different between cohorts. TRs were similar for PRPC and CPC (8.3% vs. 9.7%, p = .256); and allergic TR were significantly less with PRPC (p = .006). PC and RBC use were not increased with PRPC.DiscussionPRPC demonstrated reduced TEAMV with no excess treatment‐related pulmonary morbidity.
The doxycycline paradox in primary mitochondrial diseases
Rahman, Shamima , Kozicz, Tamás , Morava, Éva

Mayo Clinic

Journal of Inherited Metabolic Disease | June 23, 2022 | Volume: 45 | Issue: 4 | Pages: 659-660

10.1002/jimd.12531 | PMID 35734980 Get It

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma
Hasanov, Elshad , Yeboa, D.N. , Tucker, Mathew D., Swanson, Todd A. , Ene, Chibawanye , Hasanov, Merve , Derks, Sophie H. A. E. , Smits, Marion , Dudani, Shaan , Heng, Daniel Y.C., Bex, Axel , Hanalıoğlu, Şahin , Weinberg, Jeffrey S. , Hirsch, Laure , Carlo, Maria I. , Aizer, Ayal A. , Brown, Paul D. , Bilen, Mehmet Asım , Chang, Eric L. , Jaboin, Jerry J. , Choueiri, Toni K. , Halasz, Lia M. , Patel, Toral , Soltys, Scott G. , Elder, J. Bradley , Başkaya, Mustafa K. , Timmerman, Robert , Kim, Michelle Miran, Mut, Melike , Beal, Kathryn , Lang, Frederick F. , Giles, Rachel , Patel, Toral , Brown, Paul David, Choueiri, Toni K , Smits, Marion , Hanalioglu, Sahin , Patel, Toral R , Beckham, Thomas Hendrix , Rini, Brian I. , Brastianos, Priscilla K. , Brugarolas, James , Atkins, Michael B. , McGregor, Bradley A. , McDermott, David F. , Yu, James B. , Kim, Michelle H. , Markert, James M. , Tannir, Nizar , Samandouras, George , Jonasch, Eric W.

Mayo Clinic

CA: A Cancer Journal for Clinicians | June 16, 2022 | Volume: 72 | Issue: 5 | Pages: 454-489

10.3322/caac.21729 | PMID 35708940 Get It

Abstract Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited understanding of brain metastasis tumor and immune biology, drivers of resistance to systemic treatment, and their overall poor prognosis. Current data support a multimodal treatment strategy with radiation treatment and/or surgery. Nonetheless, the optimal approach for the management of brain metastases from renal cell carcinoma remains unclear. To improve patient care, the authors sought to standardize practical management strategies. They performed an unstructured literature review and elaborated on the current management strategies through an international group of experts from different disciplines assembled via the network of the International Kidney Cancer Coalition. Experts from different disciplines were administered a survey to answer questions related to current challenges and unmet patient needs. On the basis of the integrated approach of literature review and survey study results, the authors built algorithms for the management of single and multiple brain metastases in patients with renal cell carcinoma. The literature review, consensus statements, and algorithms presented in this report can serve as a framework guiding treatment decisions for patients. CA Cancer J Clin. 2022;72:454‐489.
Race, Gender, Sexuality, and the Match: A Trainee’s Call to Diversify the Electronic Residency Application Service Statistics
Cummings, Paige , Cummings, Paige E

Mayo Clinic

Academic Medicine | June 15, 2022 | Volume: 97 | Issue: 6 | Pages: 767-768

10.1097/acm.0000000000004649 | PMID 35703906 Get It